“Sonidegib Duration of Response in Advanced Basal Cell Carcinoma: Long-Term Results from the Phase 2 BOLT Trial”. 2018. SKIN The Journal of Cutaneous Medicine 2 (S1): S50. https://doi.org/10.25251/skin.2.supp.50.